A new model of cancer-related cachexia promises to help scientists understand why patients with cancer show severe wasting, which in turn may drive the development of better therapies. Cachexia refers ...

“Most people with cancer die of cachexia instead of cancer. And once the patient enters this stage, there’s no way to go back because essentially there’s no treatment," he explains. Now, Li and a team ...

Cancer cachexia is a multifactorial syndrome marked by a severe loss of body weight due primarily to the wasting of skeletal muscle and adipose tissue. This syndrome is often accompanied by systemic ...

Many cancer patients suffer from a dramatic loss of fat and muscle mass. This extreme wasting, or cachexia, is often the actual cause of death in cancer patients. Scientists have now discovered in ...

London, UK – 9 th December 2025. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and ...

Cancer is an umbrella term describing many diseases driven by the uncontrolled growth of abnormal cells. Though many of these conditions have symptoms in common, their non-specific features make ...

Two main manifestations of wasting disorders in chronic disease are cachexia and sarcopenia. Due to shared pathological features, including impairments in systemic inflammatory responses, ...

The syndrome, called cachexia, accounts for about 20% of all cancer-related deaths, statistics show. “Cancer cachexia is a serious complication affecting many patients with cancer and is characterized ...

A study describes the generation of a new mouse model that could lead to a better understanding of the cachexia syndrome. A study published in Cell Reports Aug. 6 describes the generation of a new ...

Bonnie Addario didn’t even know there was a word for what was happening to her. As if lung cancer weren’t bad enough, the 54-year-old had lost 30 pounds off her normally 130-pound frame. Her life was ...

In addition to HF, the loss of skeletal muscle mass and strength can be related to a variety of diseases, such as denervation, physical disability, fasting, ageing, and cancer. miR-29b has been ...